Peptides for pets
Peptides for pets, without the sales pitch
Last reviewed 2026-08-28
The direct answer
People are injecting research peptides - mostly BPC-157 and TB-500 - into dogs, cats and horses to try to heal injuries and slow aging. The transformation videos are real, and so is the fact that no controlled trial has tested any of these in dogs or cats. The evidence is rodent studies plus owner anecdote, the clearest known risk is cancer (these peptides grow blood vessels), and none of it is an FDA-approved animal product. This is the honest version, one species at a time.
Start with your animal
Peptides for dogs
Where the whole trend started, and where the most data - and the most marketing - lives.
Read ->Peptides for cats
The species that needs the most caution: cats process many drugs differently and there are almost no feline studies.
Read ->Peptides for horses
The oldest real-world use of these peptides - racehorse tendons are where the TB-500 story actually began.
Read ->The five peptides behind the trend
Almost every pet-peptide post, video and product comes back to these five. Each links to its full cited reference card in the library. Read the evidence line on every one - it is the part the marketing skips.
A synthetic 15-amino-acid peptide based on a protein found in stomach fluid.
Run for: Soft-tissue and ligament injuries, post-surgery recovery, and gut problems.
Evidence: The healing effects are from rodent studies; its pharmacokinetics have been measured in dogs, but no controlled trial has tested whether it works in dogs or cats.
A synthetic fragment of thymosin beta-4, a natural tissue-repair protein.
Run for: Muscle tears, tendon and ligament injuries, and recovery - with a long anecdotal history in racehorses.
Evidence: Mechanism is shown in cell and animal studies; the equine use is trainer experience, not controlled trials, and racing bodies test for it.
A three-amino-acid fragment of a natural anti-inflammatory hormone (alpha-MSH).
Run for: Gut inflammation and skin problems.
Evidence: Calmed inflammation in two mouse colitis models; no dog or cat studies exist.
A copper-binding tripeptide studied since the 1970s.
Run for: Coat, skin, wound healing and collagen support.
Evidence: Wound-healing and skin data come from human and cell studies; canine coat claims are extrapolation. Unusually light-sensitive because of its copper ion.
An immune-modulating peptide that is an approved human drug in many countries.
Run for: Older animals with repeated infections or a weak response to vaccines.
Evidence: Real human approval and human immune data; veterinary use is off-label and not backed by companion-animal trials.
Why this jumped to pets so fast
The argument that made it spread is simple: a dog cannot fake a result. A person can post a before-and-after and be dismissed as diet, lighting or something stronger. An eleven-year-old dog that could not climb the stairs and now runs up them is harder to wave away, so owners believe it in a way they never believe a human clip. That is a real insight about persuasion. It is not evidence that the peptide did the work, and a stiff old dog has good and bad weeks on its own.
The timing is the other half. A dog ages roughly seven times faster than you, so whatever a compound does shows up in months, not decades. The serious version of canine longevity is already real and funded: the FDA approved Librela, a monthly injectable antibody for arthritis pain in dogs, in 2023; Loyal is running dogs through trials for a lifespan drug; and the Dog Aging Project is testing rapamycin in 580 dogs with lifespan as the endpoint. Peptides are riding alongside that legitimate wave, at a fraction of the price and with none of the trials.
The caution the videos leave out
BPC-157 and TB-500 work partly by growing new blood vessels (angiogenesis). A tumor also needs new blood vessels to grow. That is why most veterinarians who discuss these peptides say to avoid them in any animal with known or suspected cancer. It matters here more than almost anywhere, because roughly 1 in 4 dogs develops cancer, and close to 1 in 2 dogs over 10 - the exact senior animals these are sold to help. Read the full safety and legality picture before you act on any of it.
Are peptides safe for pets? ->Tools and deeper reading
Dog peptide dosage calculator
Weight-based unit math: turn a dog's weight and a mcg/kg figure into units to draw. Math only, not a recommendation.
Open ->BPC-157 for dogs
The most-searched pet peptide, with the actual canine data - and its limits - laid out.
Open ->Are peptides safe for pets?
The cancer caution, the drug-interaction risks, and where the law (FDA GFI #256) actually stands.
Open ->Peptide regulation in 2026
The human-side compounding timeline that the pet vendors keep spinning. Dated and cited.
Open ->Sources
Each compound's full sourcing lives on its library card; the documents below back the specific claims on this page. Where a figure is community-reported rather than studied, this page says so.
- [1]Pet Owner Resources (Veterinary Cancer Society)referenceApproximately 1 in 4 dogs develops cancer in its lifetime, and almost 1 in 2 dogs over the age of 10 - the reason the caution about angiogenesis and cancer matters most in exactly the senior-dog population these peptides are marketed to. Accessed 2026-08-28.
- [2]Cancer in pets (American Veterinary Medical Association)referenceThe AVMA states roughly 1 in 4 dogs will develop cancer at some point, rising to about 1 in 2 for dogs 10 years and older. Accessed 2026-08-28.
- [3]Librela (bedinvetmab) Freedom of Information Summary - FDA approval, May 5 2023regulatoryThe FDA approved Librela (bedinvetmab), a monthly injectable monoclonal antibody for osteoarthritis pain in dogs, on 5 May 2023 - the first monoclonal antibody approved for dogs, and proof that an injectable biologic for aging dogs can clear real approval. Accessed 2026-08-28.
- [4]$7M grant rescues dog study investigating rapamycin for canine aging (AVMA)referenceThe Dog Aging Project's TRIAD trial is testing whether low-dose rapamycin extends lifespan in 580 companion dogs - a signal of how serious the canine-longevity field has become. Accessed 2026-08-28.
- [5]Upcoming Anti-Aging Drugs for Dogs: What You Need to Know (GoodRx)referenceSummarizes the emerging canine-longevity drug pipeline - Loyal's LOY-002 and the Leap Years chew among them - the legitimate, trial-backed end of the market that the peptide trend is riding alongside. Accessed 2026-08-28.
- [6]Multifunctionality and Possible Medical Application of the BPC 157 Peptide - Literature and Patent ReviewreviewReviews the animal-model evidence that BPC-157 accelerates healing of tendon, ligament, muscle and gut tissue, and that it promotes new blood vessel growth (angiogenesis) - the same mechanism behind the caution in animals with cancer. Almost all of this work is in rodents. Accessed 2026-08-28.
- [7]CVM GFI #256: Compounding Animal Drugs from Bulk Drug Substances (FDA)regulatoryFDA's guidance describing the narrow conditions under which it will not act against animal drugs compounded from bulk substances - for non-food animals, by or on the order of a licensed veterinarian, when no approved option works. A research peptide bought online and injected without a vet is outside this. Accessed 2026-08-28.
Questions people ask
Are peptides safe for dogs and cats?
No one can honestly say. The most-used pet peptides, such as BPC-157 and TB-500, have never been through a controlled safety trial in dogs or cats. What exists is rodent research, a small amount of pharmacokinetic data in dogs, and a large amount of owner anecdote. The clearest known caution is that BPC-157 promotes new blood vessel growth, which is a theoretical risk in an animal with cancer - and cancer is common in exactly the senior animals these are marketed for.
Is it legal to give my pet peptides like BPC-157?
There is no FDA-approved peptide product of this kind for animals. FDA guidance (GFI #256) allows a licensed veterinarian to have some drugs compounded from bulk substances for a non-food animal when no approved option works, under narrow conditions. A research peptide bought online and injected without a vet is outside that framework. The law is about who directs the treatment and how the drug is sourced, not just the molecule.
Why are peptides talked about more for dogs than for people?
A dog cannot report a placebo effect, so an owner who sees a stiff old dog moving better finds it far more convincing than any human before-and-after. Dogs also age about seven times faster than people, so results - good or bad - show up in months instead of decades. That combination is why the trend moved to pets so quickly, and it is a marketing fact, not evidence that the peptides work.
Which peptides do people use on pets?
The five that come up most are BPC-157 (soft-tissue and gut), TB-500 (muscle and tendon repair), KPV (gut and skin inflammation), GHK-Cu (coat, skin and wound healing) and thymosin alpha-1 (immune support in older animals). Only thymosin alpha-1 is an approved drug anywhere, and only for humans.
What are the top 3 peptides for dogs?
By how often they come up, the top three are BPC-157 (joints, soft tissue and gut), TB-500 (muscle and tendon repair, usually stacked with BPC-157), and GHK-Cu (coat and skin). Worth knowing: none of these injectables has a controlled dog trial, while oral collagen - the fourth 'peptide' people mean - actually does have canine joint studies.
What peptides can I give my dog?
There is no peptide approved for this use in dogs, so the honest answer is that this is a veterinary decision, not a menu. People use BPC-157, TB-500, GHK-Cu, KPV and thymosin alpha-1 off-label and unproven, and oral collagen as a safer, studied joint-and-coat option. Before giving your dog anything, read the safety and legality page and talk to your vet - especially because these peptides carry a cancer caution.
Pepteca is for education and information only. It does not provide medical advice, diagnosis, or treatment, and its calculators perform unit math only. Always verify with a licensed provider before starting, changing, or stopping any protocol. Many peptides are not approved for human use and may be regulated differently where you live.